World's leading clinical conference on bone, joint and muscle health
Programme
Saturday April 12 th - CEST Timezone
08:00 - 09:00
Auditorium B
Sponsored Breakfast Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
08:00 - 09:00
Non-Sponsored Symposia
08:00
Patient-centred approach to Sarcopenia: from standard of care to digital technologies
Chairpersons: Maria Luisa Brandi, Giovanni Iolascon
Chairpersons: Maria Luisa Brandi, Giovanni Iolascon
08:00
The global burden of Sarcopenia
08:00
Multimodal exercise and nutrition: the pillars of Sarcopenia treatment
08:00
Digital Technologies in Sarcopenia Treatment: the right therapy for the right patient
08:00
Closing remarks
08:00
Comprehensive Care for Pediatric Bone Fragility
Chairperson: Leith Zakraoui
Chairperson: Leith Zakraoui
08:00
Bone fragility and osteoporosis in children and adolescents: when and how to diagnose it?
08:00
Bone fragility and osteoporosis in children and adolescents: when and how to treat it?
08:00
Discussion / Q&A
08:00
Osteoporosis and Complex Regional Pain Syndrome (CRPS)
Chairperson: Ayșe A. Küçükdeveci
Chairperson: Ayșe A. Küçükdeveci
08:00
A significant problem following osteoporotic fractures: Complex Regional Pain Syndrome
08:00
Can we treat CRPS by pharmacological agents?
08:00
The role of non-pharmacological approaches in the management of CRPS
08:00
The evolution of post fracture care services in LATAM pre and post CTF mentorship programme
Chairpersons: Osvaldo Messina, Willem Lems
Chairpersons: Osvaldo Messina, Willem Lems
08:00
Qualitative and quantitative change in FLS/PFC in LATAM. An overview
08:00
Key Performance Indicators of PFC/FLS in LATAM. Expected outcomes based on BC in Mexico and Colombia
08:00
Successful country specific strategies to improve and increase the number of FLS
08:00
Challenges ahead. Gathering key data for monitoring performance and improving quality of PFC/FLS. Country specific dataset. Experience of the Argentine Hip Fracture Registry: Pasos® Program
08:00
Pregnancy and lactation, a challenge for the Bone and Muscle Health
Chairperson: Yasser El Miedany
Chairperson: Yasser El Miedany
08:00
Pregnancy, and lactation a challenge for the skeleton
08:00
Movement recommendations for Pregnant and lactating women
08:00
Abdominal aortic calcification and musculoskeletal health
Chairperson: Peter Ebeling
Chairperson: Peter Ebeling
08:00
Abdominal aortic calcification, what it is and why it is important
08:00
Abdominal aortic calcification and musculoskeletal outcomes
08:00
Abdominal aortic calcification as a novel risk factor for falls and fractures in routine clinical practice
08:00
Provision of abdominal aortic calcification results to patients
08:00 - 09:00
ESCEO Symposium: Treatment of osteoporosis and osteoarthritis in the oldest old
Chairpersons: Andrea Laslop, René Rizzoli
Chairpersons: Andrea Laslop, René Rizzoli
08:00
Specific considerations for the management of osteoporosis in the oldest old
08:00
Specific considerations for the management of osteoarthritis in the oldest old
08:00
Discussion leader
08:00 - 09:00
ISGE-ESCEO joint Symposium Session: The gynecologist and bone: A tale of woman's health
Chairpersons: Andrea Riccardo Genazzani, Şansin Tüzün
Chairpersons: Andrea Riccardo Genazzani, Şansin Tüzün
08:00
The role of sex steroids in the health of the musculoskeletal system: a lifetime journey
08:00
When the ovaries fail early: protecting the bone
08:00
Menopause and the bone: a matter for gynecologists
08:00 - 09:00
DVO-ESCEO Symposium: Special aspects of osteoporosis
Chairpersons: Ralf Schmidmaier, Olivier Bruyère
Chairpersons: Ralf Schmidmaier, Olivier Bruyère
08:00
The role of bone anabolic treatment in the geriatric population
08:00
Management of pregnancy associated osteoporosis
08:00
Osteonecrosis of the jaw: novel insights and current status
08:00
Dealing with atypical femur fractures
09:00 - 10:30
Auditorium A
Scientific Session IV
Chairpersons: Manju Chandran, Peter R. Ebeling
Chairpersons: Manju Chandran, Peter R. Ebeling
09:00
Auditorium A
Plenary Lecture
Advances in personalized fracture risk assessment: FRAX and beyond
Advances in personalized fracture risk assessment: FRAX and beyond
09:30
Auditorium A
Oral communications selected from abstracts
OC19: TBD
OC19: TBD
09:40
Auditorium A
Oral communications selected from abstracts
OC20: TBD
OC20: TBD
09:50
Auditorium A
Oral communications selected from abstracts
OC21: OSTEOSARCOPENIA AS A RISK FACTOR FOR DEPRESSION: LONGITUDINAL FINDINGS FROM THE SHARE STUDY
OC21: OSTEOSARCOPENIA AS A RISK FACTOR FOR DEPRESSION: LONGITUDINAL FINDINGS FROM THE SHARE STUDY
10:00
Auditorium A
Oral communications selected from abstracts
OC22: PSYCHOMETRIC PROPERTIES OF THE SARQOL QUESTIONNAIRE: A SYSTEMATIC REVIEW AND META-ANALYSIS
OC22: PSYCHOMETRIC PROPERTIES OF THE SARQOL QUESTIONNAIRE: A SYSTEMATIC REVIEW AND META-ANALYSIS
10:10
Auditorium A
Oral communications selected from abstracts
OC23: TBD
OC23: TBD
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:15
Auditorium A
Scientific Session V
Chairpersons: Şansin Tüzün, Ambrish Mithal
Chairpersons: Şansin Tüzün, Ambrish Mithal
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award
10:35
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards
10:40
Auditorium A
Presentation of the 2025 ESCEO-Aging Clinical and Experimental Research Award
10:45
Auditorium A
Plenary Lecture
MicroRNAs: novel risk predictors in musculoskeletal disease?
MicroRNAs: novel risk predictors in musculoskeletal disease?
11:15
Auditorium A
Oral communications selected from abstracts
OC24: TREATMENT-RELATED CHANGES IN TOTAL HIP BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION FOR TRIALS WITH ACTIVE CONTROL AND SEQUENTIAL THERAPY: THE FNIH-ASBMR-SABRE PROJECT
OC24: TREATMENT-RELATED CHANGES IN TOTAL HIP BONE MINERAL DENSITY AND FRACTURE RISK REDUCTION FOR TRIALS WITH ACTIVE CONTROL AND SEQUENTIAL THERAPY: THE FNIH-ASBMR-SABRE PROJECT
11:25
Auditorium A
Oral communications selected from abstracts
OC25: TBD
OC25: TBD
11:35
Auditorium A
Oral communications selected from abstracts
OC26: ENHANCING FRACTURE RISK PREDICTION: A COHORT-SPECIFIC MODEL INTEGRATING FRAXPLUS® VARIABLES FOR IMPROVED ACCURACY AND RECLASSIFICATION
OC26: ENHANCING FRACTURE RISK PREDICTION: A COHORT-SPECIFIC MODEL INTEGRATING FRAXPLUS® VARIABLES FOR IMPROVED ACCURACY AND RECLASSIFICATION
11:45
Auditorium A
Oral communications selected from abstracts
OC27: ENGAGEMENT WITH AND TOLERABILITY OF AUGMENTED REALITY (AR) EXERGAMES AMONG OLDER WOMEN WITH OSTEOPOROSIS: RESULTS FROM A CLINICAL TRIAL
OC27: ENGAGEMENT WITH AND TOLERABILITY OF AUGMENTED REALITY (AR) EXERGAMES AMONG OLDER WOMEN WITH OSTEOPOROSIS: RESULTS FROM A CLINICAL TRIAL
11:55
Auditorium A
Oral communications selected from abstracts
OC28: TBD
OC28: TBD
12:05
Auditorium A
Oral communications selected from abstracts
OC29: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
OC29: GLP-1 RECEPTOR AGONISTS AND RISK OF BONE FRACTURES IN ELDERLY PEOPLE WITH TYPE 2 DIABETES
12:15 - 13:45
Auditorium A
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
12:15 - 13:45
Auditorium B
Sponsored Lunch Symposium
* See details on the Sponsored Satellite Symposia page
* See details on the Sponsored Satellite Symposia page
14:00 - 15:00
Poster Viewing Session II
14:00 - 15:00
Meet-The-Expert Session
14:00
Is there a role for SYSADOAs in the management of osteoarthritis ?
14:00
Vaccination and musculoskeletal disorders
14:00
Osteoporosis management in transgender patients
14:00
Biochemical markers of bone turnover: when and which?
14:00 - 15:00
Podium
Oral presentations of selected posters
Chairperson: Elizabeth M. Curtis
Chairperson: Elizabeth M. Curtis
14:00
Podium
OP12: EVALUATING THE PRAGMATISM OF SARCOPENIA CLINICAL TRIALS USING PRECIS-2: A SYSTEMATIC REVIEW
14:06
Podium
OP13: TBD
14:12
Podium
OP14: TBD
14:18
Podium
OP15: TBD
14:24
Podium
OP16: TBD
14:30
Podium
OP17: TBD
14:36
Podium
OP18: TBD
14:42
Podium
OP19: DIFFERENTIAL ANALYSIS OF LUMBAR SPINE BONE MINERAL DENSITY AND TRABECULAR BONE SCORE IN HYPOPHOSPHATASIA PATIENTS WITH BIALLELIC VS MONOALLELIC ALPL GENOTYPE
14:48
Podium
OP20: WHICH THRESHOLD VALUES OF CROSSLAPS TO TARGET TO PREVENT BONE LOSS AT 1 AND 2 YEARS AFTER DENOSUMAB DISCONTINUATION. THE REOLAUS STUDY
14:54
Podium
OP21: TBD
14:00 - 15:00
Educational Lecture
14:00
Osteoporosis in inflammatory rheumatic musculoskeletal diseases (iRMDs)
14:00 - 15:00
ESCEO-OARSI Joint Symposium: Early knee osteoarthritis: Classification criteria for research and diagnostic criteria for clinical use
Chairpersons: Jean-Yves Reginster, Martin Englund
Chairpersons: Jean-Yves Reginster, Martin Englund
14:00
Classification criteria of early-stage symptomatic knee osteoarthritis: updates of the OARSI initiative
14:00
Diagnostic criteria for early knee osteoarthritis: Opportunities and challenges
14:00 - 15:00
ESCEO Symposium: Novel approaches to the stratified management of knee osteoarthritis: State of the art
Chairpersons: Ali Mobasheri, Roland Chapurlat
Chairpersons: Ali Mobasheri, Roland Chapurlat
14:00
The delineation of endotype and phenotype to identify the patients with knee osteoarthritis who should be treated
14:00
The role of biomarkers (imaging, biological) to identify the patients with knee osteoarthritis who should be treated
14:00
Discussion leader
14:00 - 15:00
EuGMS-ESCEO symposium: Fragility fractures: One size fits all?
Chairpersons: Nathalie van der Velde, Alvaro Casas Herrero
Chairpersons: Nathalie van der Velde, Alvaro Casas Herrero
14:00
Preventing fragility fractures in the oldest old: special considerations?
14:00
Preventing fragility fractures: similarities and differences in approaches between LMICs and Europe
14:00
Integrating fall risk prevention within fracture management: practical steps to optimize implementation
14:00 - 15:00
Educational Lecture
14:00
Biosimilars in osteoporosis management
15:00 - 16:45
Committee of Scientific Advisors Special Session: Future opportunities in the management of osteoporosis
Chairpersons: Eugene McCloskey, Etienne Cavalier
Chairpersons: Eugene McCloskey, Etienne Cavalier
15:00
Barriers and solutions for global access to osteoporosis management
15:00
Approaches to risk-based Population Screening: Insights from the ROSE study and FREM development in Denmark
15:00
The Fact and Fiction of AI in Osteoporosis
15:00 - 17:00
Auditorium A
Scientific Session VI
Chairpersons: Patricia Clark, Radmila Matijevic
Chairpersons: Patricia Clark, Radmila Matijevic
15:00
Auditorium A
Plenary Lecture
Novel concepts: assessment of intrinsic capacity
Novel concepts: assessment of intrinsic capacity
15:30
Auditorium A
Oral communications selected from abstracts
OC30: TBD
OC30: TBD
15:40
Auditorium A
Oral communications selected from abstracts
OC31: TBD
OC31: TBD
15:50
Auditorium A
Oral communications selected from abstracts
OC32: TBD
OC32: TBD
16:00
Auditorium A
Oral communications selected from abstracts
OC33: TBD
OC33: TBD
16:10
Auditorium A
Oral communications selected from abstracts
OC34: TBD
OC34: TBD
16:20
Auditorium A
Oral communications selected from abstracts
OC35: INTERACTIONS BETWEEN CALCIUM AND PROTEIN INTAKES, AND OSTEOPOROSIS MEDICATIONS ON HIP BONE STRENGTH: AN OBSERVATIONAL STUDY IN OLDER WOMEN
OC35: INTERACTIONS BETWEEN CALCIUM AND PROTEIN INTAKES, AND OSTEOPOROSIS MEDICATIONS ON HIP BONE STRENGTH: AN OBSERVATIONAL STUDY IN OLDER WOMEN
16:30
Auditorium A
Plenary Lecture
Osteoimmunology: a legacy discipline?
Osteoimmunology: a legacy discipline?
17:00 - 18:00
Educational Lecture
17:00
Pregnancy - and lactation-related osteoporosis
18:30 - 19:30
Non-Sponsored Symposia
18:30
Bone, Muscle and Fat interractions in neurodisabled persons
Chairperson: Ifigenia Kostoglou-Athanassiou
Chairperson: Ifigenia Kostoglou-Athanassiou
18:30
Introduction in bone, muscle and fat interactions
18:30
(Osteo)Sarcopenia and sarcopenic obesity in neurodisabled individuals
18:30
Sarcopenia in Hemiplegia and Stroke
18:30
Discussion in bone, muscle and fat interactions
18:30
From bone metastasis to osteoporosis - Joint IOF and CABS Symposium (Cancer and Bone Society)
Chairpersons: Patricia Juarez-Camacho, Peyman Hadji
Chairpersons: Patricia Juarez-Camacho, Peyman Hadji
18:30
Decoding skeletal complications in bone metastases
18:30
Treatment of bone metastasis – state of the art 2025
18:30
CTIBL – size of the problem and treatment options?
18:30
The Latest in Artificial Intelligence in Osteoporosis: From Large Language Models to Computer Vision
Chairperson: Nicholas Fuggle
Chairperson: Nicholas Fuggle
18:30
What are ‘A Large Language ModeIs’ and how can they be deployed in osteoporosis?
18:30
Health Equity considerations when using AI in Clinical Practice
18:30
AI for vertebral fracture screening: A UK perspective – An update from the ADOPT study
18:30
Improving and Enhancing DXA Practices; A joint symposium with ISCD and IOF
Chairpersons: Nicholas Harvey, William D. Leslie
Chairpersons: Nicholas Harvey, William D. Leslie
18:30
DXA Quality, Common Errors and Clinical Impact
18:30
The ABCs of DXA and How to Improve fractures
18:30
Expanding DXA Functionality to Enhance Clinical Care
18:30
The challenge of oral health in patients with osteoporosis: A pragmatic approach
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
Chairpersons: Jorge Luis Alberto Morales Torres, Osvaldo Daniel Messina
18:30
Introduction: Oral health and bone health. A quotidian dilemma?
18:30
The overall impact of oral health in the elderly
18:30
Osteoporotic fractures and MRONJ: Sobering statistics
18:30
Improving oral screening: the Oral Health Assessment Tool
18:30
Discussion: Whose task is it to identify oral health?
18:30
Conclusions
18:30
Skeletal fragility: The role of vitamin D and K in CKD patients
Chairpersons: Maria Fusaro, Thomas L. Nickolas
Chairpersons: Maria Fusaro, Thomas L. Nickolas
18:30
Vitamin D: from native to active form in CKD-associated
18:30
Vitamin K: instructions for use in skeletal fragility
18:30
The Statistician in detecting fraud and negligence in clinical trials
18:30
Vitamin D in Skeletal Fragility: Clinical Case
18:30
Discussion
18:30
Breaking Barriers and Advancing Bone Health for People with Intellectual Disability
Chairperson: Éilish Burke
Chairperson: Éilish Burke
18:30
The Silent Epidemic of Osteoporosis among Adults with Intellectual Disabilities
18:30
Exploring Dietary Deficiencies in Adults with Intellectual Disabilities Contributing to Poor Bone Health
18:30
Sedentary Behaviour and its Implications for the Bone Health of those with Intellectual Disability
18:30
Innovative Solutions: The Echolight Rems Device for Accessible Bone Health Screening for Adults With Intellectual Disability
18:30
New horizons in sarcopenia: From pediatric reference values to emerging therapeutic advances
Chairpersons: Gulistan Bahat, Radmila Matijevic
Chairpersons: Gulistan Bahat, Radmila Matijevic
18:30
Recognizing and managing Sarcopenia in Children: Reference muscle mass values from a European cohort
18:30
Molecular Insights, Pathways and Candidates for Novel Interventions in Sarcopenia